The Latest Analyst Ratings for Euronav
Analysts have provided the following ratings for Euronav (NYSE:EURN) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Euronav Q4 EPS $1.16 Beats $0.72 Estimate, Sales $368.07M Beat $313.89M Estimate
Euronav (NYSE:EURN) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $0.72 by 61.11 percent. This is a 422.22 percent increase over losses of $(0.36) per share from the same
Frontline Announced Earlier Confirmation That It Received From Euronav An Arbitration Request For Proceedings On The Merits Following Frontline’s Decision To Terminate The Combination Agreement
Frontline plc ("Frontline") (NYSE: FRO), formerly Frontline Ltd., confirms that it has received from Euronav NV an arbitration request for proceedings on the merits following Frontline's decision to terminate the combination agreement as further explained in Frontline's press release dated 9 January 2023.
How Did Stocks React To The December CPI Print? A Tale Of Two Narratives
Market bets on whether the Federal Reserve's rate hikes would lead to a recession in 2023 have become a primary focus for the equity markets and for those who trade them.
Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.
Benzinga’s Top Ratings Upgrades, Downgrades For January 10, 2023
Upgrades Morgan Stanley upgraded the previous rating for Stem Inc (NYSE:STEM) from Equal-Weight to Overweight. In the third…
Why VYNE Therapeutics Shares Are Trading Higher By 82%; Here Are 20 Stocks Moving Premarket
Gainers
VYNE Therapeutics Inc. (NASDAQ: VYNE) rose 82.2% to $0.35 in pre-market trading after the company said first vitiligo patient was dosed in Phase 1a/b clinical trial of novel BET inhibitor VYN201.
Stifel Downgrades Euronav to Hold, Lowers Price Target to $17
Stifel analyst Benjamin Nolan downgrades Euronav (NYSE:EURN) from Buy to Hold and lowers the price target from $20 to $17.
Euronav Acknowledged Receipt From CMB NV of a Letter to Our Supervisory Board Asking It to Terminate the Combination Agreement With Frontline; Reaffirms Commitment to Combination
Euronav NV ("EURN" or "Euronav") (NYSE: EURN & Euronext: EURN) acknowledges the receipt from CMB NV ("CMB") of a letter to our Supervisory Board asking it to terminate the Combination Agreement with Frontline Ltd. ("Frontline"), following the publication of a 13D filing in relation to the recent increase of its holdings in Euronav.